Literature DB >> 30479598

Communicable Diseases in the Mediterranean Region.

Ghassan Shannan1.   

Abstract

Communicable diseases still pose a health hazard and are a major cause of death in many parts of the world. Tuberculosis is one of the top 10 causes of death worldwide with an annual burden of 1.7 million. Global deaths in 2016 for other communicable diseases included 1.34 million from hepatitis; 1.0 million from HIV-related causes; and almost half a million from malaria. Outbreaks of vaccine-preventable diseases like polio, measles, rubella and other life-threatening diseases also pose a significant threat to various communities around the world. In this paper, we shed some light on the epidemiology of communicable diseases in the Mediterranean Region and conclude that socioeconomic differences between the north and the south Mediterranean lead to differences in the epidemiology of communicable diseases.

Entities:  

Keywords:  HIV/AIDS; communicable diseases; hepatitis; tuberculosis

Year:  2018        PMID: 30479598      PMCID: PMC6247127     

Source DB:  PubMed          Journal:  EJIFCC        ISSN: 1650-3414


INTRODUCTION

Socioeconomic, environmental and behavioural factors, as well as international travel and migration, foster and increase the spread of communicable diseases. Vaccine-preventable, foodborne, zoonotic, health care-related and communicable diseases pose significant threats to human health and may sometimes threaten international health security. In cooperation with governments, WHO/Europe develops norms and standards, guidance and public health tools to help countries implement effective disease prevention and control programmes and address their risk factors. Globally, an estimated 3 out of 10 deaths are attributed to communicable diseases. Among these, the World Health Organization (WHO) global burden of disease baseline projections in 2008 revealed that the African Region contributes the highest number of deaths with 41%, followed by the Eastern Mediterranean and South-East Asia Regions, each contributing 15% of the deaths due to infectious and parasitic diseases. WHO defines communicable disease as infectious diseases which are caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi, that can be spread, directly or indirectly, from one person to another. Under this definition, one can include a long list of diseases. However, in this publication we will focus on the most important communicable diseases, which have significant impact on public health (Table 1).
Table 1

Communicable diseases [* Vaccine-preventable communicable diseases]

HIV/AIDS* Hepatitis
Influenza* Measles
Rotavirus* Rubella
Tuberculosis* Poliomyelitis
Malaria* Diphtheria
Brucellosis* Japanese Encephalitis
Typhoid* Mumps
Cholera* Neonatal Tetanus
Sexually Transmitted Infections* Tetanus
Vector-Born & Parasitic Diseases* Yellow Fever
-* Congenital Rubella Syndrome
The review includes the countries listed in Table 2 in the Mediterranean Region.
Table 2

List of the Mediterranean region countries included in the review

Southern European Coast from West to EastLevantine Coast from North to South
GibraltarSyria
SpainCyprus
FranceLebanon
MonacoIsrael
ItalyPalestine, Gaza Strip
MaltaNorthern African Coast from East to West
Slovenia
CroatiaEgypt
Bosnia & HerzegovinaLibya
MontenegroTunisia
AlbaniaAlgeria
GreeceMorocco
Turkey-

RESULTS

Table 3 presents the population of each Mediterranean country, the expenditure on health per capita and the expenditure on health as percentage of gross domestic product (GDP). The table shows clearly the big difference in spending on health between the Northern and Southern Mediterranean countries.
Table 3

Demographic and health care spending data for countries in the Mediterranean region

CountryPopulationExpenditure on health per capita Intl. $Expenditure on health as % of GDP
Albania2,897,0006155.90
Algeria39,666,0009327.20
Bosnia & Herz.3,810,0009579.60
Croatia4,240,0001,6527.80
Cyprus1,165,0002,0627.40
Egypt91,508,0005945.60
France64,365,0004,50811.50
GibraltarN/AN/AN/A
Greece10,955,0002,0988.10
Israel8,064,0002,5997.80
Italy59,7983,2399.20
Lebanon5,851,0009876.40
Libya6,278,0008065.00
Malta419,0003,0729.80
Monaco38,0007,3024.30
Montenegro26,0008886.40
Morocco34,378,0004475.90
PalestineN/AN/AN/A
Slovenia2,068,0002,6989.20
Spain46,122,0002,9669.00
Syria18,502,0003763.20
Tunisia11,254,0007857.00
Turkey78,666,0001,0365.40

HIV/AIDS

The incidence rate in northern Mediterranean countries is higher than in southern Mediterranean countries (Table 4).
Table 4

Incidence rates of communicable diseases in Mediterranean countries

CountryHIV Incidence /105PLWHIVReceiving ART %HBVHCVTB Incidence /105MDR TB Incidence /105
Albania0.151,70030%--160.42
Algeria0.0413,00076%2.30%8.90%701.10
Bosnia & Herz.N/AN/AN/A--32N/A
Croatia0.041,50070%2.70/105-12N/A
CyprusN/AN/AN/A0.200.2/1055.6N/A
Egypt0.0311,00027%1.40%10.70%142.20
France0.21180,00078%--7.70.13
GibraltarN/AN/AN/A0.20/105-N/AN/A
GreeceN/AN/AN/A--4.40.10
IsraelN/AN/AN/A0.20/105-3.50.30
Italy0.12130,00058%0.60/1050.3/1056.10.24
Lebanon0.041,20051%--120.48
LibyaN/A4,40073%3.20%1.20%401.90
MaltaN/AN/AN/A4.20/1050.7/10513N/A
MonacoN/AN/AN/A--0N/A
Montenegro0.23<50060%--16N/A
Morocco0.0522,00048%1.80%1.60%1031.80
PalestineN/AN/AN/A--N/AN/A
SloveniaN/AN/AN/A--6.5N/A
Spain0.1814000077%1.10/105-100.50
Syria<0.0117570%3.10%0.40%212.00
Tunisia0.05290029%0.80%1.90%380.40
TurkeyN/AN/AN/A4.00%1.00%180.70
Of the people living with HIV (PLWHIV), a variable percentage are receiving anti-retroviral therapy (ART) around the Mediterranean. The lowest percentage is in Egypt, with 27%; and the highest in Spain, with 77%. There is no correlation between the expenditure on health and the number of PLWHIV (Table 4).

Hepatitis

The incidence of hepatitis A (HAV) in south Mediterranean countries is much higher than in north Mediterranean countries, especially among school children. This is also the case for the hepatitis B virus (HBV) and the hepatitis C virus (HCV), with highest incidence rate of HCV (10.70%) being in Egypt (Table 4).

Tuberculosis

The incidence rate of tuberculosis (TB) is much higher in the southern Mediterranean despite the increase of TB cases in European countries among PLWHIV. The same finding applies to multi-drug resistant (MDR) TB, where the incidence is higher in the southern Mediterranean (Table 4).

Schistosomiasis in Egypt

Schistosomiasis is a parasitic disease caused by blood flukes (Trematodes) of the genus Schistosoma (S.). It is well documented that schistosomiasis haematobium was endemic in Ancient Egypt. Infection was diagnosed in mummies 3000, 4000 and 5000 years old. Schistosomiasis haematobium was highly prevalent (60%) both in the Nile Delta and Nile Valley South of Cairo. However, by the end of 2010, in the whole country only 29 villages had a prevalence of >3% and none had more than 10%. A recent study in 2016 by a group of scientists from Tanta University report that the prevalence of S. mansoni infection was found to be 1.8% among schoolchildren of the studied areas.

Leishmaniosis in Syria

Due to the unrest in Syria over the past seven years, the incidence of leishmaniosis cases has significantly increased: from 35,876 cases in 2014; to 50,972 cases in 2015; and to 48,311 cases in 2016. Scientists attribute the increase to poor sanitation and the accumulation of rubbish and garbage around towns and villages, as many municipals authorities are not able to clear the garbage regularly.

Polio in Syria

Outbreaks of polio cases have been reported by WHO country offices in several parts of Syria (Table 5). These outbreaks are attributed to poor sanitation and the inability of International organisations to implement the immunization programme in the hard-to-reach areas.
Table 5

Syria Polio (cVDPV2) outbreak*

GovernorateDistrictNumber of cVDPV2 cases to date
Deir Ez-ZorMayadeen58
Deir Ez-Zor01
Boukamal12
RaqqaTell Abyad01
Thawra01
HomsTadmour01
Total74

* Situation Report #34, February 2018

DISCUSSION

The epidemiology of communicable diseases is affected by the socioeconomic status of the populations of the north and south Mediterranean. HIV/AIDS prevalence is higher in the northern than the southern Mediterranean countries; largely attributed to the conservative societies and the sexual behaviour of the populations, as multi-partners sexual relationships and sex outside marriage are not widespread in southern Mediterranean countries. The prevalence of hepatitis, brucellosis, typhoid, schistosomiasis and vaccine-preventable communicable diseases is much higher in the southern Mediterranean countries; mainly due to poor hygiene and inefficiency of the health systems to provide viable health services in all areas, especially in remote and hard-to-reach areas. The outbreak of Hepatitis A among schoolchildren is an example of the inefficiency of the health system to provide proper hygiene in schools and public places. More effort and funds are needed to combat many killer diseases in southern parts of the Mediterranean to eradicate hepatitis, tuberculosis, typhoid, brucellosis and other communicable diseases.
  8 in total

1.  Communicable diseases in the Eastern Mediterranean Region: prevention and control 2010-2011.

Authors:  Z Haq; J Mahjour; W Khan
Journal:  East Mediterr Health J       Date:  2013-10       Impact factor: 1.628

2.  Seroprevalance of hepatitis B and C infections in Turkey.

Authors:  Suna Yapalı
Journal:  Turk J Gastroenterol       Date:  2017-03       Impact factor: 1.852

3.  Syria's health crisis: 5 years on.

Authors:  Sharmila Devi
Journal:  Lancet       Date:  2016-03-12       Impact factor: 79.321

Review 4.  Epidemiology of Schistosomiasis in Egypt: Travel through Time: Review.

Authors:  Rashida M R Barakat
Journal:  J Adv Res       Date:  2012-09-04       Impact factor: 10.479

Review 5.  Hepatitis C in Egypt - past, present, and future.

Authors:  Ahmed Elgharably; Asmaa I Gomaa; Mary Me Crossey; Peter J Norsworthy; Imam Waked; Simon D Taylor-Robinson
Journal:  Int J Gen Med       Date:  2016-12-20

Review 6.  Hepatitis C infection in Egypt: prevalence, impact and management strategies.

Authors:  Asmaa Gomaa; Naglaa Allam; Aisha Elsharkawy; Mohamed El Kassas; Imam Waked
Journal:  Hepat Med       Date:  2017-05-15

Review 7.  Hepatitis C Virus in North Africa: An Emerging Threat.

Authors:  Mohamed A Daw; Abdallah El-Bouzedi; Mohamed O Ahmed; Aghnyia A Dau; Mohamed M Agnan
Journal:  ScientificWorldJournal       Date:  2016-08-16

Review 8.  Re-Emerging Vaccine-Preventable Diseases in War-Affected Peoples of the Eastern Mediterranean Region-An Update.

Authors:  Rasha Raslan; Skye El Sayegh; Sana Chams; Nour Chams; Angelo Leone; Inaya Hajj Hussein
Journal:  Front Public Health       Date:  2017-10-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.